 Syros Pharmaceuticals, Inc. NASDAQ:SYRS Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Courtney Solberg - Manager of Corporate Communications Investor Relations Nancy Simonian - Chief Executive Officer David Roth - Chief Medical Officer Jason Haas - Chief Financial Officer Conference Call Participants Phil Nadeau - Cowen Company Jason Butler - JMP Securities Mark Breidenbach - Oppenheimer Operator Good morning, and welcome to Syros Pharmaceuticals Second Quarter 2022 Financial Results Conference Call. At this time, all participants are in listen-only mode. 